RP
Raelipskie Partnership Portfolio holdings
AUM
$236M
1-Year Est. Return
20.12%
This Fund
S&P 500
1 Year Est. Return
+20.12%
AUM
$236M
AUM Growth
-$2.28M
(-0.96%)
Holding
128
Top Buys
| 1 | +$1.41M | |
| 2 | +$1.2M | |
| 3 | +$942K | |
| 4 |
Procter & Gamble
PG
|
+$337K |
| 5 |
Microsoft
MSFT
|
+$297K |
Top Sells
| 1 | +$1.08M | |
| 2 | +$1.04M | |
| 3 | +$357K | |
| 4 |
Apple
AAPL
|
+$303K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$300K |
Sector Composition
| 1 | Technology | 10.27% |
| 2 | Financials | 6.38% |
| 3 | Consumer Staples | 2.87% |
| 4 | Communication Services | 2.57% |
| 5 | Healthcare | 2.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.1B
| – | – |
-75
|
|
||
|
JMIA
102
Jumia Technologies
JMIA
$871M
| – | – |
-2,450
|
|
||
103
Editas Medicine
EDIT
$284M
| – | – |
-200
|
|
||
104
CRISPR Therapeutics
CRSP
$4.98B
| – | – |
-100
|
|
||
105
CME Group
CME
$105B
| – | – |
-25
|
|